Exploring a Cessation Intervention for Smokers
| Status: | Completed |
|---|---|
| Conditions: | Asthma |
| Therapuetic Areas: | Pulmonary / Respiratory Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 8/31/2017 |
| Start Date: | March 2012 |
| End Date: | March 2016 |
Exploring a Cessation Intervention for Low Income Smokers in an Emergency Setting
An estimated 6.6 million parents who smoke visit pediatric emergency departments (PED)
annually. Up to 50% of these parental smokers are from low-income, racially/ethnically
diverse households in which a variety of tobacco-related disparities (TRD) exist for both the
parents and their children. The PED is an ideal setting in which to address these
disparities, which include differences in tobacco use, pediatric second hand smoke exposure
(SHSe), quit rates, access to cessation resources, and morbidity such as cancer. The team has
conducted the only two small-scale randomized control trials (RCTs) investigating the
efficacy of providing smoking cessation counseling to parents in the PED setting. This
previous research indicates that parental smokers who visit the PED are aware of the
pediatric effects of SHSe, motivated to quit, eager to receive cessation counseling in this
setting, and show trends towards quitting.
Parents with children who have a SHSe-related illness will have higher prolonged abstinence
and point prevalence cessation rates, higher motivation to quit, greater number of quit
attempts, and lower child SHSe compared to those parents who have a child with a
non-SHSe-related illness at baseline.
annually. Up to 50% of these parental smokers are from low-income, racially/ethnically
diverse households in which a variety of tobacco-related disparities (TRD) exist for both the
parents and their children. The PED is an ideal setting in which to address these
disparities, which include differences in tobacco use, pediatric second hand smoke exposure
(SHSe), quit rates, access to cessation resources, and morbidity such as cancer. The team has
conducted the only two small-scale randomized control trials (RCTs) investigating the
efficacy of providing smoking cessation counseling to parents in the PED setting. This
previous research indicates that parental smokers who visit the PED are aware of the
pediatric effects of SHSe, motivated to quit, eager to receive cessation counseling in this
setting, and show trends towards quitting.
Parents with children who have a SHSe-related illness will have higher prolonged abstinence
and point prevalence cessation rates, higher motivation to quit, greater number of quit
attempts, and lower child SHSe compared to those parents who have a child with a
non-SHSe-related illness at baseline.
The long-range goal of my research is to test PED-based cessation interventions that are
readily translated into practice in large, multi-center trials. However, before this can
occur, preliminary data are needed, including analyses of: (1) the types of cessation
intervention components that low-income parental smokers regard as essential to their
cessation success; (2) perceived organizational barriers to the sustainability of the
intervention after the study period ends which will impede translation into practice; (3)
factors associated with parental cessation outcomes such as the presence of an acute
SHSe-related chief complaint in the child; and (4) the effect size of the intervention. This
data will be used to develop a parental cessation intervention that is tailored to low-income
parents who are likely to quit. Data from the proposed project will be used in a RO1
application to test the efficacy of this cessation intervention in a large, multi-center
randomized trial.
The proposed developmental study will be conducted in three phases. During Phase I, the
investigators will conduct focused interviews of PED nurses, physicians, and hospital
administrators to explore barriers to intervention sustainability that will assist in future
intervention planning. During Phase II, The investigators will conduct a pilot prospective
trial to examine the effectiveness of this screening, brief intervention, and assisted
referral to treatment (SBIRT) intervention on parental smoking cessation. Equal numbers of
parental smokers who bring their child to the PED for either a SHSe-related illness or non
SHSe-related illness will be given a brief intervention using an adapted form of the Clinical
Practice Guidelines: Treating Tobacco Use and Dependence. Intervention components may include
brief cessation counseling using an "Advise, Assess, and Assist" approach; information on
SHSe in children; direct connection to the Quitline (QL) in the ED; and/or free
administration of nicotine replacement therapy (NRT). The Health Belief Model will be used to
explore whether factors unique to this setting (e.g., child's acute illness) moderate the
effect of the intervention on cessation outcomes. Outcomes will be assessed following the
intervention via phone, email, or text messaging, based on parental preference. In Phase III
we will explore the feasibility of a pilot study to collect, send, analyze, and store child
saliva samples in twenty five children whose parents consent to the study. The same PED-based
SBIRT cessation intervention will be given to these parental smokers as in Specific Aim 2,
however, only English-speaking parents and parents of children who are 0-5 years of age who
present to the PED with SHSe-related illnesses will be asked if they agree to have their
child participate in this baseline and then 1-month after baseline, saliva sample collection.
These saliva samples will be analyzed to assess child cotinine levels at baseline and again
at 1 month after the SBIRT cessation intervention. Leftover saliva will be stored and frozen
indefinitely for possible future research, if parents consent.
readily translated into practice in large, multi-center trials. However, before this can
occur, preliminary data are needed, including analyses of: (1) the types of cessation
intervention components that low-income parental smokers regard as essential to their
cessation success; (2) perceived organizational barriers to the sustainability of the
intervention after the study period ends which will impede translation into practice; (3)
factors associated with parental cessation outcomes such as the presence of an acute
SHSe-related chief complaint in the child; and (4) the effect size of the intervention. This
data will be used to develop a parental cessation intervention that is tailored to low-income
parents who are likely to quit. Data from the proposed project will be used in a RO1
application to test the efficacy of this cessation intervention in a large, multi-center
randomized trial.
The proposed developmental study will be conducted in three phases. During Phase I, the
investigators will conduct focused interviews of PED nurses, physicians, and hospital
administrators to explore barriers to intervention sustainability that will assist in future
intervention planning. During Phase II, The investigators will conduct a pilot prospective
trial to examine the effectiveness of this screening, brief intervention, and assisted
referral to treatment (SBIRT) intervention on parental smoking cessation. Equal numbers of
parental smokers who bring their child to the PED for either a SHSe-related illness or non
SHSe-related illness will be given a brief intervention using an adapted form of the Clinical
Practice Guidelines: Treating Tobacco Use and Dependence. Intervention components may include
brief cessation counseling using an "Advise, Assess, and Assist" approach; information on
SHSe in children; direct connection to the Quitline (QL) in the ED; and/or free
administration of nicotine replacement therapy (NRT). The Health Belief Model will be used to
explore whether factors unique to this setting (e.g., child's acute illness) moderate the
effect of the intervention on cessation outcomes. Outcomes will be assessed following the
intervention via phone, email, or text messaging, based on parental preference. In Phase III
we will explore the feasibility of a pilot study to collect, send, analyze, and store child
saliva samples in twenty five children whose parents consent to the study. The same PED-based
SBIRT cessation intervention will be given to these parental smokers as in Specific Aim 2,
however, only English-speaking parents and parents of children who are 0-5 years of age who
present to the PED with SHSe-related illnesses will be asked if they agree to have their
child participate in this baseline and then 1-month after baseline, saliva sample collection.
These saliva samples will be analyzed to assess child cotinine levels at baseline and again
at 1 month after the SBIRT cessation intervention. Leftover saliva will be stored and frozen
indefinitely for possible future research, if parents consent.
Phase 1: Focused Interviews of Pediatric Emergency Department Practitioners will be
conducted to assess their perceived attitudes and barriers to implementing routine tobacco
screening and tobacco counseling in the pediatric emergency department.
Inclusion Criteria:
- Hospital personnel: PED medical director, Chief of Staff, Chairman of Pediatrics,
quality systems specialists, informational technology specialists, PED physicians, and
PED registered nurses.
Exclusion Criteria:
- Non-hospital personnel
Phase 2: Parental smokers who bring their children to the pediatric emergency department
will be given brief smoking cessation counseling which includes advice on quitting,
nicotine replacement therapy vouchers and direct Quitline connection.
Inclusion Criteria:
- Parent/Legal Guardian (18 years or older), who are tobacco users, accompanying a child
(0 to 18 years old) being treated in the PED with a non-urgent complaint/condition.
Exclusion Criteria:
- Parent/Legal Guardian who is only a tobacco chewer.
- Parent/Legal Guardian who is enrolled in a smoking cessation program.
- Parent/Legal Guardian who is using Nicotine Replacement Therapy (NRT) or other
cessation treatment.
- Parent/Legal Guardian who is moving within 8 months after enrollment.
Phase 3: The same PED-based SBIRT cessation intervention will be given to these parental
smokers as in Phase 2. However, parents will also be asked if they agree to have their
child participate in saliva sample collection at baseline and at one month. Parents will
also be asked if their child's leftover saliva can be stored for future research.
Inclusion Criteria:
- Parent/Legal Guardian (18 years or older), who are tobacco users, accompanying a child
(0 to 5 years old) being treated in the PED with a non-urgent second hand smoke
exposure related complaint/condition.
Exclusion Criteria:
- Parent/Legal Guardian who is only a tobacco chewer.
- Parent/Legal Guardian who is enrolled in a smoking cessation program.
- Parent/Legal Guardian who is using Nicotine Replacement Therapy (NRT) or other
cessation treatment.
- Parent/Legal Guardian who is moving within 8 months after enrollment
- Parent/Legal Guardian who does not speak or read English
We found this trial at
1
site
3333 Burnet Avenue # Mlc3008
Cincinnati, Ohio 45229
Cincinnati, Ohio 45229
1-513-636-4200
Cincinnati Children's Hospital Medical Center Patients and families from across the region and around the...
Click here to add this to my saved trials
